Results 101 to 110 of about 113,789 (245)

Using the Danish Administrative Registers to Define Mental Disorders: Potential and Limitations of Using Different Data Sources

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Although the Danish health registers provide rich data for epidemiological mental health research, the comparability of findings is hindered by different definitions of mental disorders across studies. We aimed to describe different approaches taken by researchers to define mental disorders using Danish register data and quantify ...
Natalie C. Momen, Xiaoqin Liu, Ole Köhler‐Forsberg, Bodil Hammer Bech, Oleguer Plana‐Ripoll   +4 more
wiley   +1 more source

MentalAId: an improved DenseNet model to assist scalable psychosis assessment

BMC Psychiatry
Background The escalating mental health crisis during and post-COVID-19 underscores the urgent need for scalable, timely, cost-effective assessment solutions for general psychotic disorders.
Muxi Li, Farong Liu, Fei Du, Guolin Hong, Qing Hu, Zhi-Liang Ji, Pan You   +6 more
doaj   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

A retrospective profile of consultation–liaison psychiatry practices in the perinatal period

MGM Journal of Medical Sciences
Background: Insufficient attention to antepartum and postpartum psychiatric issues in India has increased the importance of perinatal mental health within consultation–liaison psychiatry (CLP) services. Aim: This study aimed to examine the profile of CLP
Adarsh Singh, Shubhangi Dere, Rakesh Ghildiyal, Sai Sikha, Saumya Joshi   +4 more
doaj   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Promoting smoking cessation and preventing relapse to tobacco use following a smokefree mental health in‐patient stay: A multi‐centre randomised controlled feasibility study

Addiction, EarlyView.
Abstract Aims This study assessed the feasibility and acceptability of a new theory‐ and evidence‐based intervention designed to prevent return to pre‐admission smoking behaviours after discharge from a smokefree mental health in‐patient setting in the United Kingdom (UK).
Petal Petersen Williams, Lisa Huddlestone, Emily Shoesmith, Jennifer Sweetman, Heidi Stevens, Alex Mitchell, Fraser Wiggins, Lesley Sinclair, Victoria Exley, Catherine Hewitt, Judith Watson, Qi Wu, Jodi Pervin, Moira Leahy, Claire Paul, Lion Shahab, Michelle Horspool, Tim Coleman, Simon Hough, Elena Ratschen, the SCEPTRE Collaboration team, Lesley Colley, Samantha Brady, John Britton, Simon Gilbody, Steve Parrott, Peter Coventry, Gregor Russell, Paul Galdas   +28 more
wiley   +1 more source

Motives for Substance Use Among Male Psychiatric Inpatients with Psychotic Disorders

Psychiatry International
Background: Substance Use Disorder (SUD) is more prevalent among individuals with psychotic disorders than in the general population and is associated with poorer functioning, treatment adherence, and outcomes.
Cristiana Țăpoi, Emmanuel Chimdiebere Ogamdi   +1 more
doaj   +1 more source

Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas, Matthew E. Sloan, Yaoyi Xing, Ethan Kim, Dhvani Mehta, Anna Mouzenian, Lena C. Quilty, Jeffrey D. Wardell, Shannon Lange, Daniel Felsky, Victor M. Tang   +10 more
wiley   +1 more source

Methamphetamine use and HIV risk among severely mentally ill inpatients [PDF]

, 2013
Includes bibliographical references.Sub-Saharan Africa accounts for 69% of the global HIV burden. Due to a variety of social, economic and behavioural factors, mentally ill patients are more likely to engage in high risk sexual behaviours.
Moodley, Aneshree
core   +1 more source

Dysbindin (DTNBP1) - a role in psychotic depression?

, 2010
Previous studies yielded evidence for dysbindin (DTNBP1) to impact the pathogenesis of schizophrenia on the one hand and affective disorders such as bipolar or major depressive disorder (MDD) on the other.
Domschke, Katharina, C. Phillip Morris, Birosova, Eva, Tilmann Roehrs, Volker Arolt, Lawford, Bruce, Young, Ross, Arolt, Volker, Katharina Domschke, Ross Young, Young, Ross McD., Morris, C. Phillip, Bruce Lawford, Christa Hohoff, Bernhard T. Baune, Voisey, Joanne, Roehrs, Tilmann, Hohoff, Christa, Lawford, Bruce R., Baune, Bernhard T., Joanne Voisey, Eva Birosova   +21 more
core   +1 more source